References
- Teixeira AL, Salem H, Frey BN, et al. Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn. 2016;16:1209–1220. DOI:10.1080/14737159.2016.1248413
- Machado-Vieira R, Lara DR, Souza DO, et al. Purinergic dysfunction in mania: an integrative model. Med Hypotheses. 2002;58(4):297–304.
- Albert U, De Cori D, Aguglia A, et al. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J Affect Disord. 2015;173:170–175.
- Hirota T, Kishi T. Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators. Schizophr Res. 2013;149(1–3):88–95.
- Muti M, Del Grande C, Musetti L, et al. Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium. Psychiatry Res. 2015;225(3):604–608.
- Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des. 2013;19(13):2432–2438.
- Abbracchio MP, Burnstock G, Verkhratsky A, et al. Purinergic signaling in the nervous system: an overview. Trends Neurosci. 2009;32(1):19–29.
- Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev. 2007;87(2):659–797.
- Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov. 2008;7(7):575–590.
- Burnstock G, Fredholm BB, Verkhratsky A. Adenosine and ATP receptors in the brain. Curr Top Med Chem. 2011;11(8):973–1011.
- Krügel U. Purinergic receptors in psychiatric disorders. Neuropharmacology. 2016;104:212–225.
- Gomes CV, Kaster MP, Tomé AR, et al. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta. 2011;1808(5):1380–1399.
- Lindberg D, Shan D, Ayers-Ringler J, et al. Purinergic signaling and energy homeostasis in psychiatric disorders. Curr Mol Med. 2015;15(3):275–295.
- Ortiz R, Ulrich H, Zarate CA Jr, et al. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Prog Neuropsychopharmacol Biol Psychiatry. 2015;57:117–131.
- Machado-Vieira R, Soares JC, Lara DR, et al. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. J Clin Psychiatry. 2008;69(8):1237–1245.
- Machado-Vieira R. Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania. J Clin Psychopharmacol. 2012;32(5):735–736.
- Sutin AR, Cutler RG, Camandola S, et al. Impulsivity is associated with uric acid: evidence from humans and mice. Biol Psychiatry. 2014;75(1):31–37.
- Lorenzi TM, Borba DL, Dutra G, et al. Association of serum uric acid levels with emotional and affective temperaments. J Affect Disord. 2010;121(1–2):161–164.
- Akhondzadeh S, Milajerdi MR, Amini H, et al. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Bipolar Disord. 2006;8(5 Pt 1):485–489.
- Fan A, Berg A, Bresee C, et al. Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study. Bipolar Disord. 2012;14(2):206–210.
- Jahangard L, Soroush S, Haghighi M, et al. In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder. Eur Neuropsychopharmacol. 2014;24(8):1210–1221.
- Weiser M, Burshtein S, Gershon AA, et al. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Bipolar Disord. 2014;16(4):441–447.
- Bartoli F, Crocamo C, Clerici M, et al. Allopurinol as add-on treatment for mania symptoms in bipolar disorder: a systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2016. DOI:10.1192/bjp.bp.115.180281
- Bartoli F, Crocamo C, Mazza MG, et al. Uric acid levels in subjects with bipolar disorder: a comparative meta-analysis. J Psych Res. 2016;81:133–139.
- Bartoli F, Crocamo C, Gennaro GM, et al. Exploring the association between bipolar disorder and uric acid: a mediation analysis. J Psychosom Res. 2016;84:56–59.
- Bartoli F, Crocamo C, Dakanalis A, et al. Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study. Compr Psychiatry. 2016. DOI:10.1016/j.comppsych.2016.09.011
- Kapczinski F, Dal-Pizzol F, Teixeira AL, et al. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry. 2010;15(8):784–786.